Kit Hydrocodone Rgt DRI
SKU
TF-10018054
The DRI® Hydrocodone Assay is intended for the qualitative and semi-quantitative detection and estimation of Hydrocodone and its metabolites in human urine at a cutoff of 300 ng/mL. The semi-quantitative mode is for purposes of enabling laboratories to determine an appropriate dilution of specimen for confi rmation by a confi rmatory method such as LC-MS/MS or GC-MS and permitting laboratories to establish quality control measures.
| Assay Features | • Specific detection of hydrocodone • Qualitative or semi-quantitative modes • Excellent correlation to LC-MS/MS • Applications for an array of clinical chemistry analyzers • For sale in the U.S.A. and Canada only |
|---|
The DRI® Hydrocodone Assay is intended for the qualitative and semi-quantitative detection and estimation of Hydrocodone and its metabolites in human urine at a cutoff of 300 ng/mL. The semi-quantitative mode is for purposes of enabling laboratories to determine an appropriate dilution of specimen for confi rmation by a confi rmatory method such as LC-MS/MS or GC-MS and permitting laboratories to establish quality control measures. This assay provides a preliminary analytical test result. A more specifi c alternative chemical method must be used in order to confi rm an analytical result. Gas chromatography/mass spectrometry (GC/MS) and Liquid Chromatography/tandem mass spectrometry (LC-MS/MS) are the preferred confi rmatory methods.1 Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive
results are used.
We found other products you might like!
